United Therapeutics buy Wells Fargo & Company
Start price
12.06.24
/
50%
€255.70
Target price
12.06.25
€323.16
Performance (%)
19.28%
Price
09:30
€305.00
Summary
This prediction is currently active. The prediction currently has a performance of 19.28%. This prediction currently runs until 12.06.25. The prediction end date can be changed by Wells_Fargo___Compan at any time. Wells_Fargo___Compan has 50% into this predictionPerformance without dividends (%)
Name | 1w | 1m |
---|---|---|
United Therapeutics | 1.731% | 1.731% |
iShares Core DAX® | -0.543% | 1.491% |
iShares Nasdaq 100 | -2.696% | -1.235% |
iShares Nikkei 225® | -2.863% | 2.491% |
iShares S&P 500 | -1.105% | 0.013% |
Comments by Wells_Fargo___Compan for this prediction
In the thread United Therapeutics diskutieren
United Therapeutics Co. (NASDAQ: UTHR) had its price target raised by analysts at Wells Fargo & Company from $325.00 to $350.00. They now have an "overweight" rating on the stock.
Ratings data for UTHR provided by MarketBeat
Stopped prediction by Wells_Fargo___Compan for United Therapeutics
United Therapeutics
Start price
Target price
Perf. (%)
€220.00
07.03.24
07.03.24
€298.84
07.03.25
07.03.25
38.64%
09:30
09:30
United Therapeutics
Start price
Target price
Perf. (%)
€224.60
08.12.23
08.12.23
€287.40
08.12.24
08.12.24
34.55%
09:30
09:30